— Know what they know.
Not Investment Advice
Also trades as: 0UAN.L (LSE) · $vol 0M

IVZ NYSE

Invesco Ltd.
1W: +0.9% 1M: -7.7% 3M: -3.0% YTD: +6.8% 1Y: +27.0% 3Y: +148.6% 5Y: +39.4%
$28.43
-0.10 (-0.37%)
After Hours: $28.94 (+0.51, +1.79%)
Weekly Expected Move ±3.6%
$26 $27 $28 $29 $30
NYSE · Financial Services · Asset Management · Tech Score Sell · Power 36 · $12.6B mcap · 438M float · 1.09% daily turnover · Short 45% of daily vol
Credit Risk of going bust: not rated, financial company (lending is its business) Bonds: none of note held by US funds details ▾
Not rated: lending and leverage are a financial company's business, which the model misreads.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

NO EDGE
36.0 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: -2.0%  ·  5Y Avg: 2.6%
Cost Advantage
21
Intangibles
36
Switching Cost
34
Network Effect
40
Scale ★
55
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. IVZ has No discernible competitive edge (36.0/100). The business operates without significant structural advantages. The primary source of advantage is Efficient Scale. Negative ROIC of -2.0% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$31
Low
$36
Avg Target
$41
High
Based on 8 analysts since Jul 28, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 12Hold: 16Sell: 0Strong Sell: 0
Rating Summary
ConsensusHold
Avg Target$35.50
Analysts8
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-13 UBS — $41 $36 -5 +25.0% $28.80
2026-10-09 RBC Capital — $39 $36 -3 +21.3% $29.68
2026-10-09 Evercore ISI — $35 $34 -1 +14.5% $29.69
2026-10-06 UBS — Initiated $41 — +35.0% $30.38
2026-09-25 Morgan Stanley Michael Cyprys $29 $31 +2 +1.0% $30.68
2026-08-13 RBC Capital — $31 $39 +8 +21.8% $32.02
2026-08-10 Evercore ISI — $32 $35 +3 +9.2% $32.05
2026-07-29 Barclays — $31 $32 +1 +8.7% $29.43
2026-07-14 Barclays — $26 $31 +5 +9.2% $28.40
2026-07-10 Evercore ISI — $31 $32 +1 +10.1% $29.07
2026-06-08 Evercore ISI — $27 $31 +4 +11.6% $27.79
2026-04-29 Goldman Sachs Alexander Blostein $30 $30 +0 +15.9% $25.88
2026-04-29 Barclays — $29 $26 -3 +0.5% $25.88
2026-04-21 RBC Capital Kenneth Lee $33 $31 -2 +24.2% $24.95
2026-04-10 Evercore ISI — $24 $27 +3 +14.3% $23.63
2026-04-10 BMO Capital — $30 $28 -2 +18.5% $23.63
2026-01-28 RBC Capital Kenneth Lee $35 $33 -2 +18.9% $27.77
2026-01-28 Cowen & Co. — Initiated $34 — +26.5% $27.27
2026-01-28 Argus Research Stephen Biggar $33 $31 -2 +13.7% $27.25
2026-01-28 Goldman Sachs — $29 $30 +1 +8.6% $27.16
2026-01-28 Barclays — $30 $29 -1 +6.8% $27.16
2026-01-26 Morgan Stanley — $28 $29 +1 +2.1% $28.40
2026-01-21 RBC Capital Kenneth Lee $25 $35 +10 +20.9% $28.95
2026-01-15 Goldman Sachs Alexander Blostein $28 $29 +0 +1.8% $28.25
2026-01-15 Barclays Benjamin Budish $28 $30 +2 +6.2% $28.25
2026-01-06 Goldman Sachs Alexander Blostein $26 $28 +3 +0.3% $28.16
2025-12-17 Morgan Stanley — $26 $28 +2 +4.4% $26.82
2025-12-17 Deutsche Bank — $17 $31 +14 +19.1% $26.03
2025-12-12 Barclays Benjamin Budish $24 $28 +4 +3.7% $26.99
2025-12-10 BMO Capital — Initiated $30 — +13.0% $26.55
2025-11-25 Goldman Sachs — $26 $26 -1 +7.1% $23.81
2025-10-31 Fundamental Research — Initiated $27 — +14.1% $23.66
2025-10-30 RBC Capital Kenneth Lee $16 $25 +9 +4.1% $24.02
2025-10-29 Goldman Sachs — Initiated $26 — +8.8% $24.35
2025-10-21 Barclays — $19 $24 +5 +5.1% $22.84
2025-10-06 Morgan Stanley — $23 $26 +3 +8.4% $23.98
2025-09-05 Evercore ISI Glenn Schorr Initiated $24 — +9.1% $21.99
2025-07-11 Wells Fargo Michael Brown $16 $18 +2 +3.3% $17.43
2024-10-23 Barclays Benjamin Budish $25 $19 -6 +5.3% $18.04
2024-09-11 Wells Fargo Michael Brown $25 $16 -9 +1.3% $15.80
2024-04-25 RBC Capital Kenneth Lee $23 $16 -7 +10.2% $14.52
2024-04-05 Deutsche Bank Brian Bedell $24 $17 -7 +2.8% $16.53
2022-04-27 Morgan Stanley — $25 $23 -2 +21.3% $18.96
2022-04-27 Deutsche Bank Brian Bedell Initiated $24 — +26.1% $19.03
2022-04-25 Morgan Stanley — Initiated $25 — +22.6% $20.39
2022-01-23 RBC Capital Kenneth Lee Initiated $23 — +7.4% $21.41
2021-04-29 Barclays Jeremy Campbell Initiated $25 — -4.9% $26.29
2021-04-27 Argus Research Stephen Biggar Initiated $33 — +24.5% $26.51
2021-04-12 Wells Fargo Christopher Harris Initiated $25 — -0.9% $25.23

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B-
Oct 27, 2026
DCF
4
ROE
1
ROA
1
D/E
4
P/E
1
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. IVZ receives an overall rating of B-. Strongest factors: DCF (4/5), D/E (4/5). Areas of concern: ROE (1/5), ROA (1/5), P/E (1/5).
Rating Change History
DateFromTo
2026-10-12 C+ B-
2026-10-01 B- C+
2026-09-15 C+ B-
2026-09-04 B- C+
2026-09-03 C+ B-
2026-08-28 B- C+
2026-08-14 C+ B-
2026-08-12 B- C+
2026-08-07 C+ B-
2026-07-28 B- C+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 43 Grade B
Profitability
48
Balance Sheet
49
Earnings Quality
69
Growth
43
Value
49
Momentum
43
Safety
15
Cash Flow
82
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. IVZ scores highest in Cash Flow (82/100) and lowest in Safety (15/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
0.79
Distress Zone
Piotroski F-Score
6/9
✗ ✓ ✗ ✓ ✓ ✗ ✓ ✓ ✓
Beneish M-Score
-4.30
Unlikely Manipulator
Ohlson O-Score
-7.66
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
BB
Score: 40.7/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: -23.86x
Accruals: -7.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. IVZ scores 0.79, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. IVZ scores 6/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. IVZ's score of -4.30 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. IVZ's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. IVZ receives an estimated rating of BB (score: 40.7/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-41.50x
PEG
0.15x
P/S
1.77x
P/B
1.02x
P/FCF
7.36x
P/OCF
7.27x
EV/EBITDA
8.77x
EV/Revenue
1.96x
EV/EBIT
-49.08x
EV/FCF
7.53x
Earnings Yield
-0.58%
FCF Yield
13.59%
Shareholder Yield
8.37%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. IVZ currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.625
NI / EBT
×
Interest Burden
0.443
EBT / EBIT
×
EBIT Margin
-0.040
EBIT / Rev
×
Asset Turnover
0.254
Rev / Assets
×
Equity Multiplier
2.106
Assets / Equity
=
ROE
-0.6%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. IVZ's ROE of -0.6% is driven by Asset Turnover (0.254), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$28.44
Median 1Y
$29.34
5th Pctile
$14.26
95th Pctile
$60.25
Ann. Volatility
43.8%
Analyst Target
$35.50
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Andrew R. Schlossberg
President and Chief Executive Officer
$750,000 $10,084,903 $16,299,849
L. Allison Dukes
Senior Managing Director, Chief Financial Officer
$500,000 $4,021,342 $7,111,020
Douglas J. Sharp
Senior Managing Director, Head of the Americas and EMEA
$500,000 $3,297,095 $6,655,649
Andrew T.S. Lo
Senior Managing Director and Chief Executive Officer, Invesco Asia-Pacific
$500,000 $3,326,515 $6,615,347
Tony L. Wong
Senior Managing Director, Co-Head of Investments
$500,000 $3,050,864 $5,898,262
Stephanie C. Butcher
Senior Managing Director, Co-Head of Investments
$500,000 $3,023,881 $5,897,529

CEO Pay Ratio

185:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $16,299,849
Avg Employee Cost (SGA/emp): $88,078
Employees: 7,499

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
7,499
-11.9% YoY
Revenue / Employee
$850,393
Rev: $6,377,100,000
Profit / Employee
$-37,565
NI: $-281,700,000
SGA / Employee
$88,078
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
ROE 10.9% 10.4% 8.7% 7.7% 6.0% 5.7% 5.8% 5.5% -0.7% -0.7% -0.7% -1.2% 5.3% 5.5% 5.7% 7.3% -2.1% -1.8% -0.5% -0.6% -0.59%
ROA 4.7% 4.7% 4.1% 3.7% 2.9% 2.8% 2.9% 2.8% -0.3% -0.3% -0.4% -0.6% 2.8% 2.9% 2.9% 3.7% -1.0% -0.9% -0.2% -0.3% -0.28%
ROIC 6.1% 8.9% 8.5% 7.9% 4.4% 5.3% 4.6% 2.9% -1.6% -1.6% -1.6% -2.1% 3.0% 4.9% 4.7% 6.3% -2.7% -2.3% -2.9% -2.0% -1.98%
ROCE 8.7% 8.3% 7.3% 6.0% 4.7% 4.5% 4.3% 4.2% -0.6% -0.5% -0.4% -0.7% 4.1% 4.2% 4.2% 5.0% -2.0% -2.3% -1.6% -1.2% -1.18%
Gross Margin 43.4% 42.0% 42.4% 39.7% 36.9% 35.3% 35.0% 35.7% 34.3% 33.8% 36.1% 25.8% 37.8% 36.3% 33.3% 34.2% 67.0% 65.5% 99.6% 65.6% 65.64%
Operating Margin 28.9% 23.2% 22.5% 24.2% 17.0% 14.8% 14.1% 15.8% -76.1% 14.4% 13.9% 6.6% 19.6% 18.1% 14.1% 16.5% -86.2% 19.1% 19.9% 23.3% 23.30%
Net Margin 27.6% 15.8% 11.8% 16.4% 17.1% 14.4% 13.3% 13.2% -48.3% 13.6% 12.9% 7.5% 16.9% 15.1% 13.4% 21.1% -62.7% 15.4% 20.9% 17.7% 17.70%
EBITDA Margin 43.2% 24.1% 23.3% 22.2% 31.6% 21.2% 20.5% 20.1% 24.3% 23.3% 21.7% 13.4% 23.5% 26.1% 22.1% 25.0% 13.7% 20.5% 28.0% 26.3% 26.28%
FCF Margin 14.1% 9.0% 3.4% 1.3% 8.4% 13.2% 16.8% 14.8% 19.9% 20.8% 23.7% 25.0% 18.5% 17.8% 19.5% 21.9% 23.2% 27.1% 28.5% 26.0% 25.98%
OCF Margin 15.6% 10.6% 5.2% 3.7% 11.6% 16.8% 20.7% 18.3% 22.8% 23.3% 25.9% 27.0% 19.6% 18.9% 19.8% 22.1% 23.9% 27.6% 29.1% 26.3% 26.31%
ROE 3Y Avg snapshot only 1.89%
ROE 5Y Avg snapshot only 3.78%
ROA 3Y Avg snapshot only 0.92%
ROIC 3Y Avg snapshot only 1.02%
ROIC Economic snapshot only -1.86%
Cash ROA snapshot only 6.79%
Cash ROIC snapshot only 14.50%
CROIC snapshot only 14.32%
NOPAT Margin snapshot only -3.59%
Pretax Margin snapshot only -1.76%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 16.91%
SBC / Revenue snapshot only 0.28%
Valuation
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
P/E Ratio 5.48 5.74 4.79 4.65 7.78 7.59 7.78 7.08 -75.98 -69.15 -63.55 -42.83 9.81 8.29 8.60 9.87 -42.32 -45.28 -185.92 -173.41 -41.500
P/S Ratio 1.30 1.30 0.94 0.85 1.18 1.13 1.19 1.03 1.29 1.20 1.10 1.29 1.25 1.09 1.14 1.65 1.87 1.67 1.74 1.91 1.772
P/B Ratio 0.58 0.58 0.42 0.36 0.47 0.43 0.45 0.39 0.50 0.48 0.44 0.51 0.52 0.45 0.51 0.74 0.97 0.90 0.96 1.08 1.018
P/FCF 9.21 14.50 27.78 66.93 14.03 8.53 7.07 6.92 6.48 5.80 4.64 5.15 6.78 6.13 5.87 7.53 8.04 6.16 6.10 7.36 7.361
P/OCF 8.28 12.27 18.22 22.86 10.18 6.73 5.75 5.62 5.66 5.16 4.25 4.77 6.39 5.75 5.76 7.46 7.82 6.05 5.97 7.27 7.269
EV/EBITDA 5.89 3.67 3.08 3.18 9.35 4.99 5.31 9.55 11.78 11.11 9.54 11.04 10.98 4.44 5.66 6.87 14.57 15.55 8.41 8.77 8.768
EV/Revenue 2.39 1.41 1.05 0.92 2.36 1.23 1.27 2.23 2.53 2.45 2.13 2.27 2.25 0.94 1.21 1.66 3.15 3.15 1.84 1.96 1.957
EV/EBIT 6.36 3.98 3.38 3.57 10.72 5.76 6.17 11.07 -86.48 -115.66 -131.36 -73.07 12.84 5.13 6.50 7.70 -36.70 -35.77 -32.05 -49.08 -49.080
EV/FCF 17.02 15.71 30.90 72.41 28.00 9.27 7.55 15.03 12.74 11.81 9.01 9.10 12.18 5.29 6.20 7.60 13.54 11.61 6.46 7.53 7.531
Earnings Yield 18.3% 17.4% 20.9% 21.5% 12.9% 13.2% 12.9% 14.1% -1.3% -1.4% -1.6% -2.3% 10.2% 12.1% 11.6% 10.1% -2.4% -2.2% -0.5% -0.6% -0.58%
FCF Yield 10.9% 6.9% 3.6% 1.5% 7.1% 11.7% 14.1% 14.5% 15.4% 17.3% 21.6% 19.4% 14.7% 16.3% 17.0% 13.3% 12.4% 16.2% 16.4% 13.6% 13.59%
PEG Ratio snapshot only 0.149
Price/Tangible Book snapshot only 40.787
EV/OCF snapshot only 7.437
EV/Gross Profit snapshot only 2.623
Shareholder Yield snapshot only 8.37%
Leverage & Solvency
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Current Ratio 1.25 5.71 6.27 5.65 1.62 6.05 5.83 1.11 1.27 1.78 7.60 1.83 3.14 2.12 1.81 1.79 43.01 0.53 0.71 0.91 0.905
Quick Ratio 1.25 5.71 6.27 5.65 1.62 6.05 5.83 1.11 1.27 1.78 7.60 1.83 3.14 2.12 1.81 1.79 43.01 0.53 0.71 0.91 0.905
Debt/Equity 0.63 0.14 0.11 0.10 0.56 0.10 0.10 0.56 0.62 0.59 0.52 0.51 0.52 0.07 0.14 0.12 0.83 0.86 0.13 0.10 0.101
Net Debt/Equity 0.49 0.05 0.05 0.03 0.47 0.04 0.03 0.45 0.49 0.49 0.41 0.39 0.42 -0.06 0.03 0.01 0.67 0.79 0.06 0.03 0.025
Debt/Assets 0.30 0.07 0.06 0.05 0.29 0.05 0.05 0.29 0.31 0.31 0.28 0.27 0.28 0.03 0.07 0.06 0.37 0.39 0.06 0.05 0.046
Debt/EBITDA 3.47 0.79 0.74 0.81 5.60 1.04 1.08 6.31 7.36 6.78 5.82 6.15 6.07 0.74 1.44 1.07 7.35 7.90 1.07 0.80 0.805
Net Debt/EBITDA 2.70 0.28 0.31 0.24 4.66 0.40 0.34 5.15 5.79 5.66 4.63 4.79 4.87 -0.70 0.30 0.07 5.92 7.29 0.47 0.20 0.198
Interest Coverage 27.40 25.90 21.73 18.02 15.64 15.54 16.30 16.23 -2.37 -1.79 -1.42 -2.94 18.33 20.34 19.15 18.85 -6.63 -6.19 -4.10 -3.12 -3.120
Equity Multiplier 2.11 2.08 2.00 1.96 1.96 1.94 1.92 1.93 1.98 1.93 1.86 1.86 1.86 1.91 2.05 2.03 2.22 2.19 2.20 2.19 2.189
Cash Ratio snapshot only 0.266
Debt Service Coverage snapshot only 17.462
Cash to Debt snapshot only 0.754
FCF to Debt snapshot only 1.447
Defensive Interval snapshot only 62.4 days
Efficiency & Turnover
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Asset Turnover 0.20 0.21 0.21 0.21 0.19 0.19 0.19 0.20 0.19 0.20 0.21 0.21 0.22 0.22 0.22 0.22 0.24 0.24 0.25 0.25 0.254
Inventory Turnover — — — — — — — — — — — — — — — — — — — — —
Receivables Turnover 6.17 7.69 6.77 7.51 5.21 7.47 7.93 8.53 6.70 7.63 8.42 7.06 6.69 6.66 6.91 5.77 6.38 5.59 7.23 12.38 12.380
Payables Turnover 20.93 2.49 2.71 2.71 73.10 2.62 2.68 2.82 81.47 2.71 2.78 2.90 130.11 2.95 2.93 2.75 236.84 2.22 1.47 2.42 2.423
DSO 59 47 54 49 70 49 46 43 54 48 43 52 55 55 53 63 57 65 50 29 29.5 days
DIO 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.0 days
DPO 17 146 135 135 5 139 136 130 4 135 132 126 3 124 124 133 2 164 248 151 150.7 days
Cash Conversion Cycle 42 -99 -81 -86 65 -91 -90 -87 50 -87 -88 -74 52 -69 -72 -70 56 -99 -197 -121 -121.2 days
Cash Velocity snapshot only 7.390
Capital Intensity snapshot only 3.874
Growth (YoY)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue 12.2% 10.6% 2.5% -5.8% -12.3% -15.0% -13.8% -9.8% -5.5% -1.1% 1.1% 2.5% 6.1% 6.0% 5.8% 6.6% 5.1% 7.7% 12.2% 13.7% 13.65%
Net Income 1.1% 64.5% 2.9% -18.0% -43.5% -44.3% -33.0% -28.2% -1.1% -1.1% -1.1% -1.2% 9.0% 9.0% 9.1% 6.9% -1.4% -1.3% -1.1% -1.1% -1.08%
EPS 1.1% 65.4% 4.4% -16.8% -42.7% -43.9% -32.9% -27.1% -1.1% -1.1% -1.1% -1.2% 9.0% 9.0% 9.2% 6.9% -1.4% -1.3% -1.1% -1.1% -1.08%
FCF -13.1% -47.0% -83.1% -94.7% -47.4% 25.2% 3.3% 9.6% 1.2% 55.1% 42.2% 72.5% -1.4% -9.2% -13.0% -6.6% 32.2% 64.3% 64.2% 35.0% 34.97%
EBITDA 99.8% 56.0% 1.9% -27.2% -45.4% -45.6% -39.5% -26.8% -19.6% -11.4% -5.4% -9.7% 1.1% 2.0% 0.9% 25.3% 10.8% 2.8% 15.2% 4.8% 4.82%
Op. Income 94.3% 92.2% 30.3% 5.7% -26.3% -36.9% -40.5% -44.0% -1.3% -1.4% -1.4% -1.6% 2.9% 3.1% 3.1% 2.9% -1.8% -1.7% -1.5% -1.3% -1.30%
OCF Growth snapshot only 35.43%
Asset Growth snapshot only -2.79%
Equity Growth snapshot only -9.82%
Debt Growth snapshot only -21.13%
Shares Change snapshot only -0.46%
Dividend Growth snapshot only -31.39%
Growth (CAGR)
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue 3Y 9.1% 9.9% 8.3% 4.2% -0.4% -3.5% -3.9% -2.8% -2.4% -2.4% -3.7% -4.5% -4.2% -3.7% -2.7% -0.5% 1.8% 4.1% 6.3% 7.5% 7.48%
Revenue 5Y 7.8% 7.5% 6.6% 5.0% 3.2% 1.9% 1.2% 1.1% 1.5% 2.2% 2.1% 0.9% -0.2% -1.2% -1.0% 0.1% 0.7% 1.2% 1.2% 1.1% 1.08%
EPS 3Y 17.6% 18.9% 27.2% 27.9% 10.1% 10.0% 7.7% 5.3% — — — — -21.3% -19.3% -14.3% -3.0% — — — — —
EPS 5Y 10.9% 8.1% 4.3% 1.8% -6.1% -7.8% -7.5% -8.3% — — — — 2.6% 4.5% 3.2% 7.9% — — — — —
Net Income 3Y 22.7% 24.6% 29.7% 27.2% 10.2% 10.0% 7.3% 4.5% — — — — -22.0% -19.8% -14.6% -3.3% — — — — —
Net Income 5Y 13.8% 11.5% 7.4% 4.2% -4.0% -5.8% -5.6% -6.7% — — — — 2.4% 4.3% 2.8% 7.5% — — — — —
EBITDA 3Y 26.2% 25.8% 27.3% 18.9% 5.9% 5.5% 2.9% 0.2% -4.3% -9.1% -16.5% -21.6% -23.7% -21.1% -16.7% -6.1% -3.4% -2.4% 3.2% 5.9% 5.86%
EBITDA 5Y 14.9% 12.5% 8.8% 3.5% -1.4% -3.2% -3.9% -3.9% -2.5% -0.8% 3.4% 2.2% -0.7% 1.2% 0.8% 2.6% -0.4% -4.6% -7.5% -8.7% -8.74%
Gross Profit 3Y 8.4% 10.3% 9.8% 5.0% -1.0% -6.0% -7.5% -6.5% -5.7% -5.5% -7.3% -11.0% -10.6% -10.1% -10.1% -5.9% 4.1% 14.0% 30.2% 37.4% 37.40%
Gross Profit 5Y 7.8% 8.2% 7.5% 5.5% 2.6% 0.1% -1.7% -2.1% -2.0% -1.3% -0.9% -3.7% -4.2% -5.1% -5.1% -2.4% 2.9% 7.1% 12.8% 14.5% 14.50%
Op. Income 3Y 14.1% 18.9% 30.0% 29.8% 17.7% 7.5% -0.5% -4.5% — — — — -22.5% -21.1% -18.9% -12.1% — — — — —
Op. Income 5Y 8.7% 9.4% 7.6% 5.2% 0.6% -3.0% -5.7% -7.6% — — — — 0.6% -0.6% -2.5% 1.1% — — — — —
FCF 3Y 10.1% -2.1% -30.5% -51.9% -20.3% -9.8% 1.5% -5.3% 0.6% 1.0% 1.0% -1.4% 5.0% 20.8% 74.2% 1.6% 42.7% 32.3% 26.7% 29.5% 29.54%
FCF 5Y — 28.1% 2.9% -19.0% -12.9% -1.8% -1.6% -1.6% 9.4% 12.7% 15.3% 15.2% 2.1% 0.6% 5.3% 6.5% 5.8% 9.0% 8.0% 3.9% 3.85%
OCF 3Y 9.2% -1.4% -23.8% -34.4% -14.7% -5.9% 4.3% -2.3% 1.9% 1.7% 1.2% -1.3% 3.3% 16.7% 52.3% 80.4% 29.4% 23.0% 19.1% 21.4% 21.38%
OCF 5Y 52.3% 17.4% 0.4% -8.1% -9.1% 0.6% 0.7% 0.6% 9.4% 12.1% 14.0% 13.7% 1.0% -0.3% 3.1% 4.2% 4.4% 7.3% 6.7% 2.6% 2.63%
Assets 3Y 1.8% -0.4% -7.8% -8.2% -8.9% -7.0% -6.1% -6.5% -7.5% -7.0% -6.5% -5.7% -6.2% -4.0% -1.9% -1.0% -3.1% -3.4% -2.3% -2.1% -2.07%
Assets 5Y 4.9% 3.7% 1.3% -0.7% -1.2% -1.2% -1.9% -2.0% -1.4% -2.7% -6.7% -6.2% -7.3% -5.3% -4.3% -4.6% -5.8% -5.1% -3.7% -3.4% -3.37%
Equity 3Y 21.8% 21.0% 2.7% 3.2% 3.1% 4.4% 4.1% 3.1% 0.5% 0.0% -0.7% -0.7% -2.1% -1.4% -2.8% -2.1% -7.0% -7.2% -6.6% -6.1% -6.10%
Book Value 3Y 16.7% 15.4% 0.8% 3.7% 3.1% 4.4% 4.4% 3.8% 1.3% 0.8% -0.0% 0.0% -1.2% -0.8% -2.4% -1.7% -6.7% -6.9% -6.3% -6.1% -6.06%
Dividend 3Y -6.9% -3.0% -0.2% 2.2% 1.5% 1.7% 2.0% 2.3% 2.1% 1.9% 1.6% 1.6% 1.6% 1.2% 0.9% -0.2% -1.1% -2.3% -3.3% -11.9% -11.90%
Growth Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Revenue Stability 0.95 0.85 0.87 0.84 0.54 0.23 0.14 0.12 0.10 0.12 0.06 0.00 0.13 0.36 0.34 0.08 0.05 0.14 0.06 0.04 0.038
Earnings Stability 0.16 0.17 0.18 0.11 0.04 0.03 0.05 0.02 0.10 0.11 0.09 0.13 0.08 0.09 0.18 0.12 0.45 0.51 0.61 0.50 0.496
Margin Stability 0.97 0.96 0.97 0.98 0.97 0.95 0.94 0.94 0.93 0.93 0.92 0.90 0.90 0.90 0.90 0.90 0.90 0.83 0.66 0.60 0.598
Rev. Growth Consistency 1.00 0.50 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.99 0.93 0.83 0.82 0.87 0.89 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.20 0.200
Earnings Smoothness 0.27 0.51 0.97 0.80 0.44 0.43 0.60 0.67 — — — — — — — — — — — — —
ROE Trend 0.05 0.04 0.02 0.00 -0.02 -0.03 -0.03 -0.03 -0.09 -0.09 -0.08 -0.08 0.03 0.03 0.03 0.05 -0.05 -0.04 -0.03 -0.04 -0.038
Gross Margin Trend 0.01 0.02 0.02 0.02 0.00 -0.01 -0.04 -0.05 -0.06 -0.06 -0.05 -0.06 -0.04 -0.03 -0.02 0.01 0.09 0.16 0.33 0.41 0.407
FCF Margin Trend -0.03 -0.08 -0.14 -0.18 -0.08 -0.01 0.05 0.03 0.09 0.10 0.14 0.17 0.04 0.01 -0.01 0.02 0.04 0.08 0.07 0.03 0.026
Sustainable Growth Rate 7.3% 6.8% 5.0% 4.0% 2.3% 1.9% 1.9% 1.6% — — — — 1.1% 1.3% 1.5% 3.2% — — — — —
Internal Growth Rate 3.2% 3.1% 2.4% 2.0% 1.1% 0.9% 1.0% 0.8% — — — — 0.6% 0.7% 0.7% 1.6% — — — — —
Cash Flow Quality
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
OCF/Net Income 0.66 0.47 0.26 0.20 0.76 1.13 1.35 1.26 -13.42 -13.40 -14.97 -8.98 1.54 1.44 1.49 1.32 -5.41 -7.49 -31.14 -23.86 -23.858
FCF/OCF 0.90 0.85 0.66 0.34 0.73 0.79 0.81 0.81 0.87 0.89 0.92 0.93 0.94 0.94 0.98 0.99 0.97 0.98 0.98 0.99 0.987
FCF/Net Income snapshot only -23.558
OCF/EBITDA snapshot only 1.179
CapEx/Revenue 1.6% 1.6% 1.8% 2.4% 3.2% 3.5% 3.8% 3.4% 2.9% 2.5% 2.2% 2.0% 1.1% 1.2% 0.3% 0.2% 0.7% 0.5% 0.6% 0.3% 0.33%
CapEx/Depreciation snapshot only 0.013
Accruals Ratio 0.02 0.02 0.03 0.03 0.01 -0.00 -0.01 -0.01 -0.05 -0.05 -0.06 -0.06 -0.01 -0.01 -0.01 -0.01 -0.07 -0.08 -0.07 -0.07 -0.070
Sloan Accruals snapshot only -0.121
Cash Flow Adequacy snapshot only 4.368
Dividends & Buybacks
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Dividend Yield 6.1% 6.2% 8.9% 10.5% 8.0% 8.8% 8.6% 10.0% 8.1% 8.6% 9.4% 8.0% 8.0% 9.2% 8.7% 5.8% 4.9% 5.1% 4.6% 3.0% 2.97%
Dividend/Share $1.17 $1.19 $1.21 $1.23 $1.25 $1.26 $1.28 $1.30 $1.31 $1.32 $1.32 $1.33 $1.34 $1.34 $1.34 $1.31 $1.28 $1.24 $1.20 $0.90 $0.85
Payout Ratio 33.4% 35.3% 42.5% 48.7% 62.1% 66.8% 66.6% 70.8% — — — — 78.5% 75.9% 74.7% 56.8% — — — — —
FCF Payout Ratio 56.2% 89.2% 2.5% 7.0% 1.1% 75.0% 60.6% 69.2% 52.3% 50.0% 43.6% 41.2% 54.3% 56.1% 51.0% 43.3% 39.3% 31.5% 27.8% 21.9% 21.91%
Total Payout Ratio 37.1% 51.3% 61.4% 69.6% 88.7% 71.4% 88.2% 93.4% — — — — 88.7% 88.6% 90.0% 68.6% — — — — —
Div. Increase Streak 0 0 0 0 0 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0
Chowder Number -0.02 0.11 0.14 0.16 0.13 0.14 0.14 0.15 0.12 0.12 0.12 0.11 0.10 0.11 0.10 0.04 0.01 -0.03 -0.06 -0.29 -0.287
Buyback Yield 0.7% 2.8% 3.9% 4.5% 3.4% 0.6% 2.8% 3.2% 2.5% 2.6% 0.5% 0.8% 1.0% 1.5% 1.8% 1.2% 6.0% 6.7% 6.4% 5.4% 5.39%
Net Buyback Yield 0.7% 2.8% 3.9% 4.5% 3.4% 0.6% 2.8% 3.2% 2.5% 2.6% 0.5% 0.8% 1.0% 1.5% 1.8% 1.2% 6.0% 6.7% 6.4% 5.4% 5.39%
Total Shareholder Return 6.8% 8.9% 12.8% 15.0% 11.4% 9.4% 11.3% 13.2% 10.6% 11.2% 9.9% 8.8% 9.0% 10.7% 10.5% 7.0% 10.9% 11.8% 10.9% 8.4% 8.37%
DuPont Factors
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Tax Burden (NI/EBT) 0.65 0.67 0.66 0.75 0.74 0.75 0.79 0.77 0.41 0.53 0.62 0.72 0.77 0.75 0.75 0.82 0.74 0.57 0.27 0.63 0.625
Interest Burden (EBT/EBIT) 0.96 0.96 0.95 0.94 0.94 0.94 0.94 0.94 1.42 1.56 1.70 1.34 0.95 0.95 0.95 0.95 0.69 0.73 0.61 0.44 0.443
EBIT Margin 0.38 0.36 0.31 0.26 0.22 0.21 0.21 0.20 -0.03 -0.02 -0.02 -0.03 0.18 0.18 0.19 0.22 -0.09 -0.09 -0.06 -0.04 -0.040
Asset Turnover 0.20 0.21 0.21 0.21 0.19 0.19 0.19 0.20 0.19 0.20 0.21 0.21 0.22 0.22 0.22 0.22 0.24 0.24 0.25 0.25 0.254
Equity Multiplier 2.32 2.23 2.11 2.07 2.03 2.01 1.96 1.95 1.97 1.93 1.89 1.90 1.92 1.92 1.96 1.95 2.02 2.04 2.12 2.11 2.106
Per Share
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
EPS (Diluted TTM) $3.50 $3.37 $2.86 $2.52 $2.01 $1.89 $1.92 $1.84 $-0.21 $-0.22 $-0.22 $-0.39 $1.71 $1.77 $1.80 $2.31 $-0.62 $-0.54 $-0.14 $-0.17 $-0.17
Book Value/Share $33.28 $33.19 $32.89 $32.43 $33.14 $33.43 $33.41 $33.67 $32.22 $32.09 $31.98 $32.38 $32.06 $32.38 $30.57 $30.81 $26.95 $27.01 $27.45 $27.91 $30.35
Tangible Book/Share $-1.32 $-1.53 $-1.54 $-1.41 $-1.06 $-0.85 $-1.01 $-0.92 $0.13 $0.22 $0.35 $0.45 $1.08 $1.28 $-1.02 $-0.41 $-0.38 $-0.17 $0.37 $0.74 $0.74
Revenue/Share $14.81 $14.84 $14.52 $13.86 $13.18 $12.72 $12.53 $12.68 $12.62 $12.73 $12.75 $12.92 $13.36 $13.48 $13.56 $13.81 $14.05 $14.53 $15.19 $15.77 $15.89
FCF/Share $2.08 $1.33 $0.49 $0.18 $1.11 $1.68 $2.11 $1.88 $2.51 $2.64 $3.02 $3.23 $2.47 $2.40 $2.64 $3.02 $3.27 $3.94 $4.33 $4.10 $4.13
OCF/Share $2.32 $1.58 $0.75 $0.51 $1.53 $2.13 $2.59 $2.32 $2.87 $2.97 $3.30 $3.48 $2.62 $2.55 $2.69 $3.05 $3.36 $4.02 $4.42 $4.15 $4.18
Cash/Share $4.61 $2.90 $2.10 $2.27 $3.12 $1.99 $2.23 $3.43 $4.26 $3.14 $3.38 $3.60 $3.29 $4.13 $3.29 $3.35 $4.36 $1.78 $2.01 $2.13 $2.15
EBITDA/Share $6.01 $5.71 $4.94 $3.99 $3.33 $3.13 $3.00 $2.96 $2.71 $2.81 $2.85 $2.66 $2.74 $2.86 $2.89 $3.34 $3.03 $2.94 $3.33 $3.52 $3.52
Debt/Share $20.86 $4.51 $3.64 $3.24 $18.64 $3.24 $3.24 $18.69 $19.96 $19.03 $16.58 $16.36 $16.62 $2.13 $4.15 $3.57 $22.31 $23.23 $3.57 $2.83 $2.83
Net Debt/Share $16.25 $1.62 $1.54 $0.96 $15.52 $1.25 $1.01 $15.26 $15.70 $15.88 $13.20 $12.76 $13.32 $-2.00 $0.86 $0.22 $17.95 $21.45 $1.56 $0.70 $0.70
Academic Models
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 0.793
Altman Z-Prime snapshot only 0.872
Piotroski F-Score 6 8 8 5 5 6 5 4 3 4 6 5 8 8 7 8 6 5 5 6 6
Beneish M-Score -2.30 -3.01 -3.08 -2.86 -2.62 -2.33 -2.51 -2.51 -3.00 -2.65 -2.85 -2.09 -2.11 -2.05 -1.68 -2.54 -3.21 2.54 -3.34 -4.30 -4.297
Ohlson O-Score snapshot only -7.664
Net-Net WC snapshot only $-23.71
EVA snapshot only $-1550688000.00
Credit
Metric Trend Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Current
Credit Rating snapshot only BB
Credit Score 48.56 71.49 70.73 69.95 48.98 72.10 70.83 46.58 22.74 26.21 36.68 28.18 54.83 69.73 65.24 71.68 30.03 17.51 40.99 40.67 40.675
Credit Grade snapshot only 12
Credit Trend snapshot only -31.003
Implied Spread (bps) snapshot only 475.000
Industry Credit Rank snapshot only 29
Sector Credit Rank snapshot only 16

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms